Hepion Pharmaceuticals Faces Delisting Notice
Ticker: CTRVP · Form: 8-K · Filed: May 12, 2025 · CIK: 1583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (CTRVP) |
| Form Type | 8-K |
| Filed Date | May 12, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Hepion Pharmaceuticals got a notice about potentially being delisted. Big trouble ahead?
AI Summary
Hepion Pharmaceuticals, Inc. filed an 8-K on May 9, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The company was formerly known as ContraVir Pharmaceuticals, Inc. and is incorporated in Delaware.
Why It Matters
This filing indicates potential issues with Hepion Pharmaceuticals' continued listing on an exchange, which could significantly impact its stock value and trading accessibility.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued operation and investor confidence.
Key Players & Entities
- Hepion Pharmaceuticals, Inc. (company) — Registrant
- ContraVir Pharmaceuticals, Inc. (company) — Former company name
- May 9, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-36856 (identifier) — SEC File Number
FAQ
What specific listing rule or standard has Hepion Pharmaceuticals failed to satisfy?
The filing does not specify the exact rule or standard that Hepion Pharmaceuticals has failed to satisfy, only that a notice has been received.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated May 9, 2025.
What was Hepion Pharmaceuticals' former company name?
Hepion Pharmaceuticals, Inc. was formerly known as ContraVir Pharmaceuticals, Inc.
In which state is Hepion Pharmaceuticals, Inc. incorporated?
Hepion Pharmaceuticals, Inc. is incorporated in Delaware.
What is the SEC file number for Hepion Pharmaceuticals, Inc.?
The SEC file number for Hepion Pharmaceuticals, Inc. is 001-36856.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 12, 2025 regarding Hepion Pharmaceuticals, Inc. (CTRVP).